ANDA 206071, held by Navinta LLC. Methocarbamol.
As of Nov 14, 2026, ANDA 206071 (Methocarbamol), held by Navinta LLC, was first approved by FDA on Nov 24, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 24, 2017 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Methocarbamol1GM/10ML (100MG/ML) ยท solution;im-iv | Methocarbamol | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
